Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
1.
Cell Mol Gastroenterol Hepatol ; 10(3): 623-637, 2020.
Article in English | MEDLINE | ID: mdl-32474164

ABSTRACT

BACKGROUND AND AIMS: The Extra-Uterine Environment for Neonatal Development (EXTEND) aims to avoid the complications of prematurity, such as NEC. Our goal was to determine if bowel development occurs normally in EXTEND-supported lambs, with specific emphasis on markers of immaturity associated with NEC. METHODS: We compared terminal ileum from 17 pre-term lambs supported on EXTEND for 2- 4 weeks to bowel from age-matched fetal lambs that developed in utero. We evaluated morphology, markers of epithelial integrity and maturation, enteric nervous system structure, and bowel motility. RESULTS: EXTEND-supported lamb ileum had normal villus height, crypt depth, density of mucin-containing goblet cells, and enteric neuron density. Expression patterns for I-FABP, activated caspase-3 and EGFR were normal in bowel epithelium. Transmural resistance assessed in Ussing chambers was normal. Bowel motility was also normal as assessed by ex vivo organ bath and video imaging. However, Peyer's patch organization did not occur normally in EXTEND ileum, resulting in fewer circulating B cells in experimental animals. CONCLUSION: EXTEND supports normal ileal epithelial and enteric nervous system maturation in pre-term lambs. The classic morphologic changes and cellular expression profiles associated with NEC are not seen. However, immune development within the EXTEND supported lamb bowel does not progress normally.


Subject(s)
Enterocolitis, Necrotizing/prevention & control , Extracorporeal Membrane Oxygenation/methods , Fetal Organ Maturity/immunology , Ileum/embryology , Premature Birth/therapy , Animals , Animals, Newborn , Disease Models, Animal , Enterocolitis, Necrotizing/immunology , Female , Fetus/immunology , Humans , Ileum/immunology , Infant, Newborn , Intestinal Mucosa/embryology , Intestinal Mucosa/immunology , Premature Birth/immunology , Sheep , Umbilical Cord/blood supply
2.
Am J Physiol Lung Cell Mol Physiol ; 302(4): L380-9, 2012 Feb 15.
Article in English | MEDLINE | ID: mdl-22160306

ABSTRACT

The proinflammatory stimulus of chorioamnionitis is commonly associated with preterm delivery. Women at risk of preterm delivery receive antenatal glucocorticoids to functionally mature the fetal lung. However, the effects of the combined exposures of chorioamnionitis and antenatal glucocorticoids on the fetus are poorly understood. Time-mated ewes with singleton fetuses received an intra-amniotic injection of lipopolysaccharide (LPS) either preceding or following maternal intramuscular betamethasone 7 or 14 days before delivery, and the fetuses were delivered at 120 days gestational age (GA) (term = 150 days GA). Gestation matched controls received intra-amniotic and maternal intramuscular saline. Compared with saline controls, intra-amniotic LPS increased inflammatory cells in the bronchoalveolar lavage and myeloperoxidase, Toll-like receptor 2 and 4 mRNA, PU.1, CD3, and Foxp3-positive cells in the fetal lung. LPS-induced lung maturation measured as increased airway surfactant and improved lung gas volumes. Intra-amniotic LPS-induced inflammation persisted until 14 days after exposure. Betamethasone treatment alone induced modest lung maturation but, when administered before intra-amniotic LPS, suppressed lung inflammation. Interestingly, betamethasone treatment after LPS did not counteract inflammation but enhanced lung maturation. We conclude that the order of exposures of intra-amniotic LPS or maternal betamethasone had large effects on fetal lung inflammation and maturation.


Subject(s)
Betamethasone/therapeutic use , Chorioamnionitis/drug therapy , Fetal Development/drug effects , Glucocorticoids/therapeutic use , Lung/embryology , Amnion , Animals , Bronchoalveolar Lavage Fluid/cytology , Chorioamnionitis/etiology , Chorioamnionitis/immunology , Cytokines/genetics , Cytokines/metabolism , Female , Fetal Organ Maturity/drug effects , Fetal Organ Maturity/immunology , Gene Expression , Inflammation/drug therapy , Inflammation/immunology , Lipopolysaccharides/pharmacology , Lung/drug effects , Lung/enzymology , Lung/immunology , Male , Medroxyprogesterone Acetate/therapeutic use , Peroxidase/metabolism , Phosphatidylcholines/metabolism , Pregnancy , Premature Birth/immunology , Premature Birth/prevention & control , Pulmonary Surfactant-Associated Protein C/genetics , Pulmonary Surfactant-Associated Protein C/metabolism , Pulmonary Surfactant-Associated Protein D/genetics , Pulmonary Surfactant-Associated Protein D/metabolism , Random Allocation , Sheep , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolism
3.
Am J Physiol Lung Cell Mol Physiol ; 296(3): L510-8, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19112099

ABSTRACT

Little is known about the effects of fetal ethanol exposure on lung development. Our aim was to determine the effects of repeated ethanol exposure during late gestation on fetal lung growth, maturation, and inflammatory status. Pregnant ewes were chronically catheterized at 91 days of gestational age (DGA; term approximately 147 days). From 95-133 DGA, ewes were given a 1-h daily infusion of either 0.75 g ethanol/kg (n = 9) or saline (n = 8), with tissue collection at 134 DGA. Fetal lungs were examined for changes in tissue growth, structure, maturation, inflammation, and oxidative stress. Between treatment groups, there were no differences in lung weight, DNA and protein contents, percent proliferating and apoptotic cells, tissue and air-space fractions, alveolar number and mean linear intercept, septal thickness, type-II cell number and elastin content. Ethanol exposure caused a 75% increase in pulmonary collagen I alpha1 mRNA levels (P < 0.05) and a significant increase in collagen deposition. Surfactant protein (SP)-A and SP-B mRNA levels were approximately one third of control levels following ethanol exposure (P < 0.05). The mRNA levels of the proinflammatory cytokines interleukin (IL)-1beta and IL-8 were also lower (P < 0.05) in ethanol-exposed fetuses compared with controls. Pulmonary malondialdehyde levels tended to be increased (P = 0.07) in ethanol-exposed fetuses. Daily exposure of the fetus to ethanol during the last third of gestation alters extracellular matrix deposition and surfactant protein gene expression, which could increase the risk of respiratory distress syndrome after birth. Changes to the innate immune status of the fetus could increase the susceptibility of the neonatal lungs to infection.


Subject(s)
Ethanol/toxicity , Fetus/drug effects , Fetus/immunology , Immunity, Innate/drug effects , Lung/drug effects , Lung/immunology , Maternal-Fetal Exchange/immunology , Animals , Base Sequence , Collagen/metabolism , Collagen Type I/genetics , Collagen Type I, alpha 1 Chain , Cytokines/genetics , DNA Primers/genetics , Elastin/metabolism , Ethanol/administration & dosage , Female , Fetal Organ Maturity/drug effects , Fetal Organ Maturity/genetics , Fetal Organ Maturity/immunology , Gene Expression/drug effects , Immunity, Innate/genetics , Inflammation Mediators/metabolism , Lung/embryology , Lung/metabolism , Oxidative Stress , Pregnancy , Pulmonary Surfactant-Associated Proteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sheep
4.
Am J Obstet Gynecol ; 200(2): 195.e1-10, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19110233

ABSTRACT

BACKGROUND: Antenatal pulmonary inflammation is associated with reduced risk for respiratory distress syndrome but with an increased risk for bronchopulmonary dysplasia (BPD) with impaired alveogenesis. OBJECTIVE: We hypothesized that fetal systemic inflammation induced by intravenous (IV) lipopolysaccharide (LPS) would affect lung development in utero. STUDY DESIGN: Twenty-one fetal sheep were instrumented (107 days gestational age). Control fetuses received saline (N = 12) and 9 in the study group received 100 ng of LPS IV 3 days after surgery. Animals were assessed for lung maturation and structure after 3 (N = 5) and 7 (N = 4) days. RESULTS: Interleukin-6 concentration increased in the bronchoalveolar lavage more than 40-fold 3 days after LPS IV. Processing of pro-surfactant protein (SP)-B to mature SP-B and increased SP-B concentrations were shown 7 days after LPS IV. Deposition of elastin fibers at sites of septation was disturbed within 3 days after LPS IV. CONCLUSION: Lung maturation and disturbed lung structure occurred after short-term exposure to fetal inflammation and suggests new targeted therapies for BPD.


Subject(s)
Fetal Diseases/immunology , Fetal Organ Maturity/immunology , Lipopolysaccharides/administration & dosage , Lung Diseases/immunology , Lung/immunology , Animals , Cell Proliferation , Elastin/immunology , Female , Fetus , Lung/growth & development , Lung Compliance , Pulmonary Surfactant-Associated Protein B/immunology , Sheep
6.
Semin Pediatr Surg ; 14(3): 137-44, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16084400

ABSTRACT

The pathogenesis of necrotizing enterocolitis (NEC) is poorly understood, but appears to be multifactorial and highly associated with immaturity of the gastrointestinal tract, colonization of the intestinal microbiota, and immature innate immune system. The goal of this review is to provide an overview of some of these risk factors and how they might lead to the genesis of NEC. A better understanding of these factors should help us prevent and treat this devastating disease.


Subject(s)
Enterocolitis, Necrotizing/immunology , Immunity, Innate/immunology , Intestines/immunology , Enterocolitis, Necrotizing/physiopathology , Fetal Organ Maturity/immunology , Humans , Infant, Newborn , Infant, Premature/immunology , Intestines/physiopathology
7.
J Gynecol Obstet Biol Reprod (Paris) ; 30(1 Suppl): 21-6, 2001 Feb.
Article in French | MEDLINE | ID: mdl-11240514

ABSTRACT

Despite improvement in neonatal care, the incidence of bronchopulmonary dysplasia has not decreased over the last decade. Moreover, chronic lung disease still occurs in very premature infants who do not require ventilatory support at birth. This review presents the growing body of epidemiological, experimental and clinical evidence suggesting that the occurrence of an inflammatory reaction triggered in utero or immediately after birth is associated with the subsequent development of chronic lung disease. However, stimulators of inflammation or specific proinflammatory cytokines may also have beneficial on lung maturation. How proinflammatory mediators interfere with lung maturation and alveolarization needs to be better understood in order to pave the way for new immunomodulatory strategies to prevent chronic lung disease in very preterm infants.


Subject(s)
Bronchopulmonary Dysplasia/etiology , Bronchopulmonary Dysplasia/immunology , Chorioamnionitis/complications , Chorioamnionitis/immunology , Lung/embryology , Respiratory Distress Syndrome, Newborn/etiology , Respiratory Distress Syndrome, Newborn/immunology , Bronchopulmonary Dysplasia/epidemiology , Bronchopulmonary Dysplasia/therapy , Chorioamnionitis/therapy , Cytokines/immunology , Female , Fetal Organ Maturity/immunology , Humans , Incidence , Infant, Newborn , Inflammation , Pregnancy , Respiration, Artificial/adverse effects , Respiratory Distress Syndrome, Newborn/epidemiology , Respiratory Distress Syndrome, Newborn/therapy , Risk Factors , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL